Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3
Condition: Primary Breast Cancer Intervention: Drug: SPECT Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Research | Russia Health | SPECT